Stories tagged: "Johnson & Johnson"


Acting state Secretary of Health Alison Beam speaks during a news conference on Tuesday, April 13, 2021. She said that the pause in administering the Johnson & Johnson vaccine is "out of an abundance of caution." (Screenshot)
Pennsylvania Joins National Pause on J&J Vaccine

Health officials said the pause is being made “out of an abundance of caution.”

People wait in line at a 24-hour, walk-up COVID-19 vaccination clinic hosted by the Black Doctors COVID-19 Consortium at Temple University's Liacouras Center in Philadelphia, Friday, Feb. 19, 2021. (AP Photo/Matt Rourke)
A Third Coronavirus Vaccine Is on Its Way to Pennsylvania After FDA Approves Johnson & Johnson Shot

Reports released by the FDA showed Johnson & Johnson’s vaccine was 86% effective at preventing severe cases of COVID-19 and 100% effective at preventing death in the United States.

This Sept. 2020 photo provided by Johnson & Johnson shows a clinician preparing to administer investigational Janssen COVID-19 vaccine. Johnson & Johnson's long-awaited COVID-19 vaccine appears to protect against symptomatic illness with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. Johnson & Johnson said Friday, Jan. 29, 2021 that in the U.S. and seven other countries, the first single-shot vaccine appears 66% effective overall at preventing moderate to severe COVID-19. It was more protective against severe symptoms, 85%. (Johnson & Johnson via AP)
Johnson & Johnson: Study Shows Our One-Shot Vaccine is Effective

The first one-shot COVID-19 vaccine provides good protection against the illness, Johnson & Johnson reported in a key study.

The addition of the Johnson & Johnson vaccine to the United States' arsenal of COVID vaccines—which so far includes one each from Pfizer and Moderna—could make vaccinating large numbers of people easier, once the supply is ready. (Anadolu Agency Photo via Getty Images/Eva Marie Uzcategui Trinkl)
Johnson & Johnson’s COVID Vaccine Could Be Approved Soon. Here’s Why That’s a Big Deal.

If effective, Johnson & Johnson's one-dose vaccine could quickly help large swaths of the United States develop immunity to COVID-19. That would be a game changer.